Adectris: Pfizer medication achieves positive results in advanced-stage blood cancer study
Pfizer announced that a combined treatment involving its medication, Adcetris, has achieved the primary objective in a late-stage study aimed at prolonging survival among...
Web DeskMarch 12, 2024
Facebook
Twitter
Instagram
LinkedIn
RSS